Search results
Rapport Therapeutics Prices 8M Share IPO at $17/sh By Investing.com
Investing.com· 2 days agoRapport Therapeutics, Inc. (Nasdaq: RAPP) today announced the pricing of its initial public offering...
Sterling Shepard says Baker Mayfield got the ball rolling on his signing with the Bucs
ProFootball Talk on NBC Sports via Yahoo Sports· 16 hours agoBaker Mayfield and Sterling Shepard have been reunited in Tampa Bay, playing together for the first...
J&J-backed Rapport Therapeutics valued at $636.8 mln in lukewarm debut
Reuters· 1 day agoJohnson & Johnson-backed Rapport Therapeutics' shares rose nearly 6% above the initial public offering price on Friday, in a tepid debut for the early-stage therapy developer.
Rapport talks up $122M IPO to support proof-of-concept epilepsy trials
FierceBiotech· 6 days agoRapport Therapeutics is talking up a $122 million IPO, the first in a return to public market...
Third Rock’s Rapport reveals upsized $154M IPO
FierceBiotech· 2 days agoJust a few days after Rapport Therapeutics revealed plans for a $122 million IPO, the epilepsy biotech has unveiled an upsized $154 million offering....
Death in Paradise star 'didn't look back' after deciding to quit acting
Daily Express· 3 hours agoSergeant JP Hooper, portrayed by Tobi Bakare, bid farewell to Death in Paradise at the conclusion of...
Rapport Therapeutics raises up to $154 million in IPO - Boston Business Journal
The Business Journals· 2 days agoRapport Therapeutics Inc. said late Thursday it has raised $154 million in an initial public offering. Rapport (Nasdaq: RAPP), a Boston-based maker of small-molecule ...
J&J-backed Rapport Therapeutics seeks about $637 million valuation in US IPO
Reuters via Yahoo News· 6 days agoThe U.S. IPO market is staging a strong comeback after two dismal years, thanks to a rally in the stock market and growing optimism of a possible interest rate cut this year. Rapport ...
Fox’s New Quiz Show The 1% Club Is Great, But Patton Oswalt Is Its Biggest Win For Me
CinemaBlend via Yahoo News· 5 days agoIt can take a long time to find the right rhythm and establish arapport with the contestants. For...
Rapport Therapeutics Prices 8 Million-Share IPO at $17 per Share
Market Watch· 2 days agoPublished: June 6, 2024 at 7:11 p.m. ETShareResizeBy Stephen NakrosisAbout Dow Jones NewswiresDow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the
